Published Studies Related to Enalapril and Hydrochlorothiazide (Enalapril / Hydrochlorothiazide)
Well-designed clinical trials related to Enalapril and Hydrochlorothiazide (Enalapril / Hydrochlorothiazide)
Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril. [2009.03]
Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide. [2008.10]
Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. [2006.01]
Well-designed clinical trials possibly related to Enalapril and Hydrochlorothiazide (Enalapril / Hydrochlorothiazide)
Pharmacotherapy review of chronic pediatric hypertension. [2011.10]
Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. [2008.03]
The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects. [2006.11]
Other research related to Enalapril and Hydrochlorothiazide (Enalapril / Hydrochlorothiazide)
Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril. [2010]
Pharmacodynamics of kardos administered as monotherapy and in combination with hypothiazide and enalapril in grade I-II arterial hypertension. [2009.08]
Cough induced by losartan with resolution after substitution with enalapril. [2008.03]
Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance. [2007.10]
Other possibly related research studies
C-reactive protein (CRP)-lowering agents. [2006.03]
Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease. [2006.05]
Insulin glulisine. [2006]
Angiotensin-converting enzyme inhibitors and obstructive sleep apnea. [2006.01]
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy. [2006.06]
Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats. [2006.01]
Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats. [2006.02]
Drug-induced pancreatitis: an update. [2005.09]
A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. [2005]
Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage. [2007.03]
Dechallenge and rechallenge method showed different incidences of cough among four ACE-Is. [2007.06]
Beneficial Effects of Eplerenone Versus Hydrochlorothiazide on Coronary Circulatory Function in Patients with Diabetes Mellitus. [2007.05.08]
Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus. [2007.07]
Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. [2007]
Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren. [2007.09]
Risk of acute liver injury associated with the use of drugs: a multicentre population survey. [2007.06.15]
Reduction of blood pressure variability by combination therapy in spontaneously hypertensive rats. [2007.11]
Reducing global cardiovascular risk in patients with type 2 diabetes mellitus. [2008.05]
Low-dose transdermal hormone therapy does not interfere with the blood pressure of hypertensive menopausal women: a pilot study. [2008.10]
Renoprotect and blood pressure lowering effect of low-dose hydrochlorothiazide added to intensive renin-angiotensin inhibition in hypertensive patients with chronic kidney disease. [2009.08]
[Effect of total flavonoids of Hippophae rhamnoides L. on the expression of MCP-1 in aorta of spontaneously hypertensive rats] [2009.05]
Irbesartan and hydrochlorothiazide association in the treatment of hypertension. [2009.04]
Effect of antihypertensive therapy on serum lipids in newly diagnosed essential hypertensive men. [2009.04]
A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors. [2010.08]
Eprosartan: a review of its use in hypertension. [2009]
Effect of antihypertensive drug therapy on short-term heart rate variability in newly diagnosed essential hypertension. [2010.02]
Combination delapril/manidipine as antihypertensive therapy in high-risk patients. [2011]
Impact of hypertension, aging, and antihypertensive treatment on the morphology of the pudendal artery. [2011.04]
A pilot double-blind randomised placebo-controlled trial of the effects of
fixed-dose combination therapy ('polypill') on cardiovascular risk factors. [2010]
Mineralocorticoid receptor blockade improves coronary microvascular function in
individuals with type 2 diabetes. [2015]
|